6 nominees · 4 ballot items.
Elect six directors; ratify Fruci & Associates II, PLLC as auditors; approve an increase in shares reserved under the 2021 Omnibus Equity Incentive Plan to 4,800,000; and approve an evergreen provision to automatically increase the plan share reserve annually (5% cap) from Jan 1, 2027 through the plan’s initial ten-year term.
Elect six (6) directors to serve until the 2027 annual meeting.
Ratify Fruci & Associates II, PLLC as the Company’s independent registered public accounting firm for fiscal year ending December 31, 2026.
Amend the 2021 Omnibus Equity Incentive Plan to increase the number of Class A common shares reserved for awards from 800,000 to 4,800,000.
This management-sponsored proposal requests stockholder approval to amend the Company’s 2021 Omnibus Equity Incentive Plan to increase the share reserve from 800,000 to 4,800,000 Class A shares. Management and the Compensation Committee state the amendment is necessary because only 28,738 shares remain available under the plan as of the record date and, without an increase, the company expects insufficient shares to grant competitive equity awards needed to attract, retain and motivate employees and non-employee directors. The proposal explains that the board considered dilution, historical burn rate and overhang, forecasted grants, strategic growth plans, and the competitive market for talent in setting the requested increase. Approval would enable continued use of equity incentives, which management argues align employees’ interests with stockholders and promote long-term value creation. The amendment authorizes the plan administrator broad discretion over award types, terms, and recipients while maintaining certain limitations (e.g., no repricing without stockholder approval). The board recommends a FOR vote, citing the importance of equity compensation as a tool for retention and alignment. Key governance considerations include potential dilution to current holders, the breadth of administrator discretion, change-in-control and clawback provisions, and the plan’s ten-year term. An analyst should weigh the operational need for future grants against dilution impact, plan overhang, historical grant practices, and whether alternative retention tools exist.
Amend the 2021 Plan to add an evergreen provision that, beginning January 1, 2027 and through the plan’s initial ten-year term, automatically increases the share reserve annually by the lesser of 5% of outstanding shares or a smaller number determined by the board.
This management proposal asks shareholders to approve an amendment adding an annual 'evergreen' share replenishment to the 2021 Omnibus Equity Incentive Plan so that on each January 1 from 2027 through the plan’s initial ten-year term the plan’s share reserve will increase by the lesser of 5% of outstanding shares or a lesser amount set by the board. Management argues the evergreen ensures a continuous supply of shares for grants, reducing the need for frequent additional shareholder approvals and enabling consistent retention and hiring via equity awards. The board’s recommendation is premised on operational convenience and the strategic need to maintain competitive equity award capacity; the committee expects the provision could cover approximately four years of awards at current grant practices assuming maximum annual increases. Material governance considerations include the dilutionary effect of an uncapped multi-year replenishment (subject only to the 5%-per-year formula), broad administrator discretion in grant terms, and the absence of explicit annual shareholder re-approval beyond this vote. From an investor-analytic perspective, the evergreen increases predictability of award capacity but raises concerns about cumulative dilution, especially if the share price declines or grant volumes rise. Analysts should review historical burn rates, current overhang, potential future hiring needs, and whether the board’s authority to set a smaller annual amount provides meaningful restraint. The presence of clawback and change-in-control provisions partially mitigates executive risk-taking and windfalls, but does not address dilution for long-term holders. Overall, the proposal balances operational flexibility against the risk of multi-year dilution; its merits depend on the company’s growth prospects, planned hiring and historical equity usage.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 4.16% | 3,360,425 | $8M |
| 2 | BlackRock, Inc. | 0.80% | 649,273 | $2M |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.75% | 605,139 | $1M |
| 4 | UBS Group AG | 0.58% | 472,172 | $1M |
| 5 | MILLENNIUM MANAGEMENT LLC | 0.55% | 445,228 | $1M |
| 6 | VANGUARD FIDUCIARY TRUST CO | 0.47% | 379,931 | $881K |
| 7 | Penserra Capital Management LLC | 0.45% | 363,175 | $843K |
| 8 | STATE STREET CORP | 0.38% | 307,222 | $713K |
| 9 | SLT Holdings LLC | 0.33% | 269,750 | $626K |
| 10 | FOUNDATIONS INVESTMENT ADVISORS, LLC | 0.33% | 269,750 | $626K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.